Avenue Biosciences is a transatlantic biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Avenue Biosciences has developed a proprietary protein engineering platform that allows the simultaneous analysis of thousands of natural and synthetic signal peptides to boost therapeutic protein production. Our technology has wide applications across mRNA therapies, gene therapy vectors, antibody engineering, biosimilars, de novo proteins and more. Visit: www.avenuebiosciences.com.